Diagnosis and Treatment of ST-Segment Elevation Myocardial Infarction (original) (raw)

Abstract

ST-segment elevation myocardial infarction (STEMI) represents the Priority group of the PAIN pathway. This diagnosis should be promptly ascertained and the proper treatment algorithm (see Chapter 2, Figs. 2.1 and 2.4 to 2.6) immediately applied to maximize the preservation of ischemic myocardium at risk and minimize the acute and late morbidity/mortality [1, 2]. The American College of Cardiology/American Heart Association (ACC/ AHA) guidelines on STEMI [3] suggest that all patients presenting to the emergency department (ED) with a history of chest pain or symptoms suggestive of STEMI should undergo the following:

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (47)

  1. Berger PB, Ellis SG, Holmes DR Jr, et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation 1999;100: 14-20.
  2. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to- balloon time and door-to-balloon time with mortality in patients undergoing angio- plasty for acute myocardial infarction. JAMA 2000;283:2941-2947.
  3. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the manage- ment of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guide- lines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004;110:e82-292.
  4. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombo- lytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
  5. McGrath PD, Wennberg DE, Dickens JD Jr, et al. Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. JAMA 2000;284:3139-3144.
  6. Boersma E, Maas AC, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771-775.
  7. Zeymer U, Tebbe U, Essen R, et al. Infl uence of time to treatment on early infarct- related artery patency after different thrombolytic regimens. ALKK-Study Group. Am Heart J 1999;137:34-38.
  8. Appleby P, Baigent C, Collins R, et al. Indications for fi brinolytic therapy in sus- pected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 1994;343:311- 322.
  9. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated vs hospital- initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA 1993;270:1211-1216.
  10. Emergency department: rapid identifi cation and treatment of patients with acute myocardial infarction. National Heart Attack Alert Program Coordinating Commit- tee, 60 Minutes to Treatment Working Group. Ann Emerg Med 1994;23:311-329.
  11. Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis. JAMA 2000;283:2686-2692.
  12. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angio- plasty Substudy Investigators. N Engl J Med 1997;336:1621-1628.
  13. Grines CL, Cox DA, Stone GW, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myo- cardial Infarction Study Group. N Engl J Med 1999;341:1949-1956.
  14. The effects of tissue plasminogen activator, streptokinase, or both on coronary- artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angiographic Investigators. N Engl J Med 1993;329:1615-1622.
  15. Bode C, Smalling RW, Berg G, et al. Randomized comparison of coronary throm- bolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators. Circula- tion 1996;94:891-898.
  16. Cannon CP, Gibson CM, McCabe CH, et al. TNK-tissue plasminogen activator com- pared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators. Circula- tion 1998;98:2805-2814.
  17. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantita- tive review. JAMA 1997;278:2093-2098.
  18. Neuhaus KL, von Essen R, Tebbe U, et al. Improved thrombolysis in acute myocar- dial infarction with front-loaded administration of alteplase: results of the rt-PA- APSAC patency study (TAPS). J Am Coll Cardiol 1992;19:885-891.
  19. White HD, French JK, Hamer AW, et al. Frequent reocclusion of patent infarct- related arteries between 4 weeks and 1 year: effects of antiplatelet therapy. J Am Coll Cardiol 1995;25:218-223.
  20. Wilson SH, Bell MR, Rihal CS, et al. Infarct artery reocclusion after primary angio- plasty, stent placement, and thrombolytic therapy for acute myocardial infarction. Am Heart J 2001;141:704-710.
  21. Meijer A, Verheugt FW, Werter CJ, et al. Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study. Circulation 1993;87:1524-1530.
  22. Takens BH, Brugemann J, van der Meer J, et al. Reocclusion three months after successful thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activating complex. Am J Cardiol 1990;65:1422-1424.
  23. Nijland F, Kamp O, Verheugt FW, et al. Long-term implications of reocclusion on left ventricular size and function after successful thrombolysis for fi rst anterior myocardial infarction. Circulation 1997;95:111-117.
  24. Antoniucci D, Santoro GM, Bolognese L, et al. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial. J Am Coll Cardiol 1998;31:1234- 1239.
  25. Antoniucci D, Valenti R, Buonamici P, et al. Direct angioplasty and stenting of the infarct-related artery in acute myocardial infarction. Am J Cardiol 1996;78: 568-571.
  26. Kastrati A, Pache J, Dirschinger J, et al. Primary intracoronary stenting in acute myocardial infarction: long-term clinical and angiographic follow-up and risk factor analysis. Am Heart J 2000;139:208-216.
  27. Rodriguez A, Bernardi V, Fernandez M, et al. In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial). Gianturco-Roubin in Acute Myocardial Infarction. Am J Cardiol 1998;81:1286-1291.
  28. Suryapranata H, van't Hof AW, Hoorntje JC, et al. Randomized comparison of coro- nary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998;97:2502-2505.
  29. Kurisu S, Sato H, Kawagoe T, et al. Tako-tsubo-like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction. Am Heart J 2002;143:448-455.
  30. Stone GW, Grines CL, Browne KF, et al. Infl uence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy. Am J Cardiol 1996;78:19-25.
  31. Henriques JP, Zijlstra F, van't Hof AW, et al. Primary percutaneous coronary inter- vention versus thrombolytic treatment: long term follow up according to infarct location. Heart 2006;92:75-79.
  32. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999;341:625-634.
  33. Wu AH, Parsons L, Every NR, Bates ER. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 2002;40:1389-1394.
  34. Bradley EH, Herrin J, Wang Y, et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med 2006;355:2308-2320.
  35. Bonnefoy E, Lapostolle F, Leizorovicz A, et al. Primary angioplasty versus pre- hospital fi brinolysis in acute myocardial infarction: a randomised study. Lancet 2002;360:825-829.
  36. Widimsky P, Budesinsky T, Vorac D, et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J 2003;24: 94-104.
  37. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angio- plasty with fi brinolytic therapy in acute myocardial infarction. N Engl J Med 2003; 349:733-742.
  38. Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated percutane- ous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomized trials. Lancet 2006;367:579-588.
  39. Ellis SG, da Silva ER, Heyndrickx G, et al. Randomized comparison of rescue angio- plasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation 1994;90:2280-2284.
  40. Kennedy JW, Ritchie JL, Davis KB, et al. Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med 1983;309:1477-1482.
  41. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2: 349-360.
  42. Cigarroa RG, Lange RA, Hillis LD. Prognosis after acute myocardial infarction in patients with and without residual anterograde coronary blood fl ow. Am J Cardiol 1989;64:155-160.
  43. Lange RA, Cigarroa RG, Hillis LD. Infl uence of residual antegrade coronary blood fl ow on survival after myocardial infarction in patients with multivessel coronary artery disease. Coron Artery Dis 1990;1:59-63.
  44. Lamas GA, Flaker GC, Mitchell G, et al. Effect of infarct artery patency on prognosis after acute myocardial infarction. Circulation 1995;92:1101-1109.
  45. Hochman JS, Lamas GA, Buller CE, et al., for the Occluded Artery Trial Investigators. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 2006;355:2395-2407.
  46. Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefi ned-a consen- sus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefi nition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969.
  47. Ohman EM, Armstrong PW, White HD, et al. Risk stratifi cation with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries. Am J Cardiol 1999; 84:1281-1286.